JPMorgan Chase & Co’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-101,118
| Closed | -$203K | – | 4918 |
|
2018
Q1 | $203K | Buy |
101,118
+99,018
| +4,715% | +$199K | ﹤0.01% | 3717 |
|
2017
Q4 | $3K | Sell |
2,100
-18,760
| -90% | -$26.8K | ﹤0.01% | 4593 |
|
2017
Q3 | $26K | Buy |
20,860
+4,200
| +25% | +$5.24K | ﹤0.01% | 3938 |
|
2017
Q2 | $22K | Buy |
16,660
+510
| +3% | +$673 | ﹤0.01% | 3914 |
|
2017
Q1 | $30K | Sell |
16,150
-8,713
| -35% | -$16.2K | ﹤0.01% | 4040 |
|
2016
Q4 | $129K | Buy |
+24,863
| New | +$129K | ﹤0.01% | 3809 |
|